Nigeria's drug stockpiles surge by 65% in Q1’24, as inflation squeezes consumer spending

Nigeria’s drug stockpiles surge by 65% in Q1’24, as inflation squeezes consumer spending

Paracetamol

Nigeria’s rising inflation impacts pharmaceuticals, with firms' finished goods inventory increasing by 64.6 percent in Q1 2024, Businessday findings show. Fidson Healthcare, May & Baker Nigeria, Mecure, and Neimeth reported N15.8 billion in finished goods in Q1 2024, up from N9.6 billi

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```